| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:40 UTC |
|---|
| HMDB ID | HMDB0014592 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Dipivefrin |
|---|
| Description | Dipivefrin is only found in individuals that have used or taken this drug. It is a prodrug of adrenaline, which is used to treat glaucoma. It is available as ophthalmic solution (eye drops). Dipivefrin is a prodrug with little or no pharmacologically activity until it is hydrolyzed into epinephrine inside the human eye. The liberated epinephrine, an adrenergic agonist, appears to exert its action by stimulating α- and/or β2-adrenergic receptors, leading to a decrease in aqueous production and an enhancement of outflow facility. The dipivefrin prodrug delivery system is a more efficient way of delivering the therapeutic effects of epinephrine, with fewer side effects than are associated with conventional epinephrine therapy. |
|---|
| Structure | CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1 InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate | ChEBI | | 1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol | ChEBI | | 4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate | ChEBI | | Dipivalyl epinephrine | ChEBI | | Dipivefrina | ChEBI | | Dipivefrine | ChEBI | | Dipivefrinum | ChEBI | | (+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid | Generator | | 4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid | Generator | | Alcon brand OF dipivefrin hydrochloride | HMDB | | Diopine | HMDB | | Glaucothil | HMDB | | PMS-Dipivefrin | HMDB | | Pharm-allergan brand OF dipivefrin hydrochloride | HMDB | | Propine | HMDB | | Dipivaloylepinephrine | HMDB | | Dipivefrin perchlorate | HMDB | | Apo-dipivefrin | HMDB | | Glaudrops | HMDB | | Adrenaline dipivalate | HMDB | | Dipivefrin acetate, (+-)-isomer | HMDB | | Dipivefrin monophosphate, (+-)-isomer | HMDB | | Dipivefrin monosulfate, (+-)-isomer | HMDB | | Dipivefrin tartrate (1:1), (+-)-(R-(r*,r*))-isomer | HMDB | | Allergan brand OF dipivefrin hydrochloride | HMDB | | Dipoquin | HMDB | | Ioquin brand OF dipivefrin hydrochloride | HMDB | | Pharmascience brand OF dipivefrin hydrochloride | HMDB | | Ratiopharm brand OF dipivefrin hydrochloride | HMDB | | D Epifrin | HMDB | | Dipivefrin citrate (1:1), (+-)-isomer | HMDB | | Dipivefrin nitrate, (+-)-isomer | HMDB | | Dipivefrin propanoate, (+-)-isomer | HMDB | | Dipivefrin tartrate (1:1), (R)-(R-(r*,r*))-isomer | HMDB | | Apotex brand OF dipivefrin hydrochloride | HMDB | | Dipivefrin hydrochloride | HMDB | | Dipivefrin hydrochloride, (+-)-isomer | HMDB | | Dipivefrin, (R)-isomer | HMDB | | Ratio-dipivefrin | HMDB |
|
|---|
| Chemical Formula | C19H29NO5 |
|---|
| Average Molecular Weight | 351.4373 |
|---|
| Monoisotopic Molecular Weight | 351.204573043 |
|---|
| IUPAC Name | 2-[(2,2-dimethylpropanoyl)oxy]-5-[1-hydroxy-2-(methylamino)ethyl]phenyl 2,2-dimethylpropanoate |
|---|
| Traditional Name | dipivefrin |
|---|
| CAS Registry Number | 52365-63-6 |
|---|
| SMILES | CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1 |
|---|
| InChI Identifier | InChI=1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 |
|---|
| InChI Key | OCUJLLGVOUDECM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenol esters. These are aromatic compounds containing a benzene ring substituted by a hydroxyl group and an ester group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenol esters |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Phenol esters |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenol ester
- Phenoxy compound
- Aralkylamine
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- 1,2-aminoalcohol
- Amino acid or derivatives
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Secondary aliphatic amine
- Secondary amine
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Alcohol
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.058 g/L | Not Available | | LogP | 1.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.81 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.2914 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.85 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 37.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1870.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 199.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 166.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 159.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 73.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 447.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 469.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 125.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 917.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 431.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1448.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 326.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 224.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 273.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Dipivefrin,1TMS,isomer #1 | CNCC(O[Si](C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 | 2150.6 | Semi standard non polar | 33892256 | | Dipivefrin,1TMS,isomer #2 | CN(CC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C | 2318.0 | Semi standard non polar | 33892256 | | Dipivefrin,2TMS,isomer #1 | CN(CC(O[Si](C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C | 2294.9 | Semi standard non polar | 33892256 | | Dipivefrin,2TMS,isomer #1 | CN(CC(O[Si](C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C | 2426.3 | Standard non polar | 33892256 | | Dipivefrin,2TMS,isomer #1 | CN(CC(O[Si](C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C | 2573.9 | Standard polar | 33892256 | | Dipivefrin,1TBDMS,isomer #1 | CNCC(O[Si](C)(C)C(C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 | 2368.3 | Semi standard non polar | 33892256 | | Dipivefrin,1TBDMS,isomer #2 | CN(CC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2573.1 | Semi standard non polar | 33892256 | | Dipivefrin,2TBDMS,isomer #1 | CN(CC(O[Si](C)(C)C(C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2784.2 | Semi standard non polar | 33892256 | | Dipivefrin,2TBDMS,isomer #1 | CN(CC(O[Si](C)(C)C(C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2808.8 | Standard non polar | 33892256 | | Dipivefrin,2TBDMS,isomer #1 | CN(CC(O[Si](C)(C)C(C)(C)C)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2808.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Dipivefrin GC-MS (Non-derivatized) - 70eV, Positive | splash10-052f-9150000000-30a32fb00720193ce912 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dipivefrin GC-MS (1 TMS) - 70eV, Positive | splash10-0a4l-9044000000-b32f8d364631e20e4017 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dipivefrin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 10V, Positive-QTOF | splash10-0f89-0049000000-cef336a5e244ea16b9f1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 20V, Positive-QTOF | splash10-0kai-4059000000-c483238390ca6a1eaa68 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 40V, Positive-QTOF | splash10-0a59-9351000000-607bb994262a9b103492 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 10V, Negative-QTOF | splash10-0udi-0109000000-2ce96b91437661fde684 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 20V, Negative-QTOF | splash10-0ue9-2449000000-59429e2be741d17c8117 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 40V, Negative-QTOF | splash10-0udi-3910000000-eb3054746367b77b8eed | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 10V, Positive-QTOF | splash10-0ue9-0019000000-4099393ff81d85a0ef03 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 20V, Positive-QTOF | splash10-0f89-0059000000-459602b5970b064ff34c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 40V, Positive-QTOF | splash10-0a4i-9383000000-22ec9c056edfb61e9b13 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 10V, Negative-QTOF | splash10-0udi-0019000000-6628a7bbb51fbe187be7 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 20V, Negative-QTOF | splash10-0udi-0759000000-ec60a4f35ccc46b4a95a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dipivefrin 40V, Negative-QTOF | splash10-0f79-6692000000-669ea5989d4d3ee82487 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|